https://www.optometrytimes.com/view/nordic-group-bv-announces-commercial-launch-of-lacrifill-canalicular-gel Introducing Lacrifill Canalicular Gel: A Novel Dry Eye Therapy Now Commercially Available in the U.S. Nordic Group B.V., through its U.S. subsidiary Nordic Pharma, has officially launched Lacrifill® Canalicular Gel, a new interventional dry eye treatment now commercially available in the United States. This innovative therapy offers eyecare professionals a targeted approach to managing dry eye disease (DED) by […]
Continue Reading... No Comments.